Sign in

You're signed outSign in or to get full access.

Peter Conley

Chief Financial Officer at KNW
Executive

About Peter Conley

Peter J. Conley serves as Chief Financial Officer and Senior Vice President, Intellectual Property at Know Labs, Inc. since May 2022, following an employment agreement executed on May 13, 2022 . He concurrently is Senior Managing Director and Head of Intellectual Property Banking at Boustead Securities, LLC (since October 2014), and previously co-founded and served as COO of ipCreate (2012–2016), with prior leadership roles at ipCapital Venture Group, MDB Capital Group, The Analytiq Group/RDEX Research, Roth Capital Partners, Lehman Brothers, and was on the founding team and Head of Equity Capital Markets at EOffering, the investment bank of ETrade . Conley attended the University of Hawaii at Manoa and the University of London, Center for Financial & Management Studies (SOAS) . The company disclosed “Pay Versus Performance” information generally, but did not provide executive-specific TSR or EBITDA growth metrics tied to Mr. Conley; compensation actuals and performance measure linkages beyond option awards were not detailed for him .

Past Roles

OrganizationRoleYearsStrategic Impact
ipCreateCo‑Founder and COO2012–2016Global IP development and innovation services for multinationals
ipCapital Venture GroupManaging DirectorIP strategy and venture advisory services
EOffering (ETrade’s investment bank)Founding team; Head of Equity Capital MarketsBuilt equity capital markets capability for a new investment bank
MDB Capital Group; The Analytiq Group/RDEX Research; Roth Capital Partners; Lehman BrothersLeadership rolesCapital markets and research leadership across firms

External Roles

OrganizationRoleYearsStrategic Impact
Boustead Securities, LLCSenior Managing Director & Head of IP BankingSince Oct 2014Provides equity financing and M&A advisory services to small‑cap public companies

Fixed Compensation

ComponentPeriodAmount/Terms
Base SalaryEmployment agreement effective May 13, 2022$300,000 base salary
Base SalaryDec 14, 2022 – Sep 30, 2023$325,000 annual salary
BonusOngoingDiscretionary bonus determined by Board or Compensation Committee; no target % disclosed
SeveranceIf terminated without “cause” or for “good reason”12 months of then‑in‑effect base salary
Employment TermAt‑willEither party may terminate at any time, with or without cause, upon written notice
ExpensesOngoingReimbursement for reasonable travel, entertainment, and other business expenses

Performance Compensation

Grant DateAward TypeShares/UnitsStrike/Exercise PriceExpirationVesting
May 20, 2022Stock Options1,000,000$1.485 yearsVests quarterly over 4 years; no vesting during first 6 months
Oct 10, 2023Stock Options3,001,000$0.255 yearsVests quarterly over 4 years
Jun 4, 2025 (contingent; pending shareholder approval)Stock Options107,500$0.50Contingent on shareholder approval; awarded in context of recipients having previously voluntarily cancelled historic option grants to support the Company’s continued operation

Notes:

  • Reverse stock split of 1‑for‑40 became effective on February 19, 2025; share references in 2025 plan disclosures reflect post‑split amounts .
  • The 2025 contingent awards to Mr. Conley (107,500 options at $0.50) were approved by the Board subject to stockholder approval .

Equity Ownership & Alignment

MetricJun 30, 2024Dec 31, 2024Jun 20, 2025
Direct Shares Owned (#)10,000 10,000 50,250
Options Exercisable within 60 Days (#)1,062,688 1,750,375 — (not disclosed)
Total Beneficial Ownership (#)1,072,688 — (not disclosed)50,250
Ownership % of Shares Outstanding1.2% <1% (based on 111,166,117 OS shares) — (7,497,297 OS shares disclosed; Conley individually shown without %)*

*Shares outstanding: 85,822,200 as of Jun 30, 2024 ; 111,166,117 as of Dec 31, 2024 ; 7,497,297 as of Jun 20, 2025 (post‑split) . Company policy prohibits hedging and limits pledging/margin holdings to not more than 25% of total shares owned by the employee/director .

Employment Terms

TermDetail
At‑Will EmploymentEither party may terminate at any time, with or without cause, upon written notice
Severance12 months of then‑in‑effect base salary if terminated without “cause” or for “good reason”
Bonus EligibilityDiscretionary, determined by Board/Compensation Committee; no target % disclosed
ExpensesReimbursement of reasonable business expenses
Anti‑Hedging & Anti‑PledgingHedging prohibited; pledging/margin permitted only up to 25% of total shares owned; policy applies to officers and directors

Investment Implications

  • Option‑heavy pay design ties upside to share appreciation via sizable option grants (2022: 1,000,000 @ $1.48; 2023: 3,001,000 @ $0.25), with multi‑year vesting that encourages retention; absence of disclosed cash bonus targets reduces near‑term cash comp pressure .
  • In 2025, executives including Mr. Conley received contingent option awards (107,500 @ $0.50), approved by the Board subject to shareholder approval, following voluntary cancellation of historic option grants to preserve equity capital—supportive for alignment but implies future vest‑related supply if approved .
  • Beneficial ownership shifted materially around the 1‑for‑40 reverse split effective Feb 19, 2025; Conley’s reported beneficial stake moved from 1,072,688 (1.2%) pre‑split to 50,250 shares post‑split, with options not disclosed in the 2025 table—reducing near‑term selling pressure visibility and highlighting reliance on new grants for alignment .
  • Severance set at 12 months base salary (no disclosed bonus multiple) and strict anti‑hedging/limited pledging policy lower agency risk; concurrent external role at Boustead Securities may offer capital markets expertise, but investors should monitor potential conflicts and time allocation .